Skip to main content
. 2023 Apr 4;15(7):2138. doi: 10.3390/cancers15072138

Figure 2.

Figure 2

Analysis of the expression of miRNA-146a-5p in HER2+ breast cancer patients. (A) Levels of miR-146a-5p expression measured in disease-free HER2+ BC patients (n = 13) and relapsed HER2+ BC patients (n = 20) via RT-qPCR. miR-16a was used as endogenous miRNA. (B) Patients (n = 33) were classified based on median miR-146a-5p expression in tumor samples, and DFS Kaplan-Meier curve was plotted (p-value = 0.043). * p-value < 0.05. HR: Hazard ratio; DFS: Disease-free survival.